Entrada Therapeutics (TRDA) Payables (2020 - 2026)
Entrada Therapeutics (TRDA) posted Payables of $3.75 million for Q2 2026, up 101.7% from $1.86 million a year earlier and up 27.8% from the prior quarter.
Powered by 
Analysis
Entrada Therapeutics (TRDA) Payables (2020 - 2026) Analysis & Trends
At the end of FY2025, Entrada Therapeutics' Payables came in at $2.29 million, down 46.3% from FY2024.
- Annual Payables shows a five-year compound annual growth rate of 7.4% (FY2020 to FY2025).
- In prior years, Entrada Therapeutics' Payables was $4.26 million in FY2024 (+30.0%), $3.28 million in FY2023 (-45.3%), $5.99 million in FY2022 (+748.4%) and $706,000 in FY2021 (-55.9%).
- The Q2 2026 figure stands as the highest quarterly Payables since Q4 2024.
- On a year-over-year basis, Payables increased in six of the last eight quarters, with growth averaging 42.0%.
- The strongest year-over-year quarter for Payables in the past five years was Q4 2022, with growth of 748.4%; the weakest was Q1 2024, with a decline of 61.0%.
- According to Business Quant data, Payables for the three prior quarters was $2.93 million (Q1 2026), $2.29 million (Q4 2025) and $3.17 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 20.92 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 33.30 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 5.96 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 4.26 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | -22.89 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 2.87 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 674.00 Mn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 7.03 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 429.50 Mn |
| 10 | Entrada Therapeutics | 242.19 Mn | 242.19 Mn | - | 3.75 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 3.75 Mn |
| Mar 31, 2026 | 2.93 Mn |
| Dec 31, 2025 | 2.29 Mn |
| Sep 30, 2025 | 3.17 Mn |
| Jun 30, 2025 | 1.86 Mn |
| Mar 31, 2025 | 2.19 Mn |
| Dec 31, 2024 | 4.26 Mn |
| Sep 30, 2024 | 1.29 Mn |
| Jun 30, 2024 | 1.64 Mn |
| Mar 31, 2024 | 2.53 Mn |
| Dec 31, 2023 | 3.28 Mn |
| Sep 30, 2023 | 752,000.00 |
| Jun 30, 2023 | 2.42 Mn |
| Mar 31, 2023 | 6.47 Mn |
| Dec 31, 2022 | 5.99 Mn |
| Sep 30, 2022 | 1.34 Mn |
| Jun 30, 2022 | 4.62 Mn |
| Mar 31, 2022 | 2.93 Mn |
| Dec 31, 2021 | 706,000.00 |
| Sep 30, 2021 | 2.28 Mn |
API Access
Entrada Therapeutics Payables API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=payables&ticker=TRDA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "payables", "ticker": "TRDA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=payables&ticker=TRDA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();